DNMT3A and angioimmunoblastic T-cell lymphoma: [23, 25, 26] Loss of function mutations in DNMT3A, a DNA methyltransferase that is required for genome-wide de novo methylation, are frequent in a variety of malignancies and have been reported in up to 38% of PTCL, NOS and 33%-37% AITL.